1. Home
  2. KRYS vs KC Comparison

KRYS vs KC Comparison

Compare KRYS & KC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • KC
  • Stock Information
  • Founded
  • KRYS 2015
  • KC 2012
  • Country
  • KRYS United States
  • KC China
  • Employees
  • KRYS N/A
  • KC N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • KC Computer Software: Prepackaged Software
  • Sector
  • KRYS Health Care
  • KC Technology
  • Exchange
  • KRYS Nasdaq
  • KC Nasdaq
  • Market Cap
  • KRYS 3.6B
  • KC 3.8B
  • IPO Year
  • KRYS 2017
  • KC 2020
  • Fundamental
  • Price
  • KRYS $125.96
  • KC $11.17
  • Analyst Decision
  • KRYS Strong Buy
  • KC Strong Buy
  • Analyst Count
  • KRYS 8
  • KC 3
  • Target Price
  • KRYS $211.13
  • KC $7.47
  • AVG Volume (30 Days)
  • KRYS 436.2K
  • KC 2.0M
  • Earning Date
  • KRYS 05-06-2025
  • KC 05-28-2025
  • Dividend Yield
  • KRYS N/A
  • KC N/A
  • EPS Growth
  • KRYS 109.01
  • KC N/A
  • EPS
  • KRYS 4.16
  • KC N/A
  • Revenue
  • KRYS $333,448,000.00
  • KC $1,099,631,090.00
  • Revenue This Year
  • KRYS $48.66
  • KC $26.97
  • Revenue Next Year
  • KRYS $49.81
  • KC $18.91
  • P/E Ratio
  • KRYS $30.31
  • KC N/A
  • Revenue Growth
  • KRYS 247.53
  • KC 14.67
  • 52 Week Low
  • KRYS $122.80
  • KC $2.02
  • 52 Week High
  • KRYS $219.34
  • KC $22.26
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 31.65
  • KC 34.43
  • Support Level
  • KRYS $123.03
  • KC $11.49
  • Resistance Level
  • KRYS $127.59
  • KC $13.30
  • Average True Range (ATR)
  • KRYS 4.59
  • KC 0.46
  • MACD
  • KRYS 0.39
  • KC -0.27
  • Stochastic Oscillator
  • KRYS 18.15
  • KC 6.70

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About KC Kingsoft Cloud Holdings Limited

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

Share on Social Networks: